Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Becker

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Plos Medicine|March 24, 2005
Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGDRoland Haubner, Wolfgang A Weber, Ambros J Beer, et al.
Plos One|August 23, 2012
Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomasJulia Slotta-Huspenina, Daniela Berg, Karina Bauer, et al.
Endocrine-Related Cancer|March 31, 2007
The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cellsMaría Jesús Larriba, Noelia Valle, Héctor G Pálmer, et al.
Cancer Research|February 5, 2008
Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutationsAnja Bremm, Axel Walch, Margit Fuchs, et al.
New Biotechnology|December 10, 2023
Inter-patient heterogeneity in the hepatic ischemia-reperfusion injury transcriptome: Implications for research and diagnosticsSilvia Groiss, Christian Viertler, Marcel Kap, et al.
Histopathology|March 8, 2012
Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissuesClaudia Schuster, Katharina Malinowsky, Sibylle Liebmann, et al.
International Journal of Cancer|September 5, 2002
CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancerPaul D P Pharoah, Carla Oliveira, José Carlos Machado, et al.
Radiation Research|April 25, 2003
Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted (d9) E-cadherin adhesion proteinMatthias Miederer, Christof Seidl, Gerd-Jürgen Beyer, et al.
Journal of Proteome Research|November 9, 2012
Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phaseSibylle Gündisch, Stefanie Hauck, Hakan Sarioglu, et al.
Experimental Cell Research|May 25, 2002
Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitorsMargit Fuchs, Peter Hutzler, Ingrid Brunner, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Plos Medicine|March 24, 2005
Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGDRoland Haubner, Wolfgang A Weber, Ambros J Beer, et al.
Plos One|August 23, 2012
Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomasJulia Slotta-Huspenina, Daniela Berg, Karina Bauer, et al.
Endocrine-Related Cancer|March 31, 2007
The inhibition of Wnt/beta-catenin signalling by 1alpha,25-dihydroxyvitamin D3 is abrogated by Snail1 in human colon cancer cellsMaría Jesús Larriba, Noelia Valle, Héctor G Pálmer, et al.
Cancer Research|February 5, 2008
Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutationsAnja Bremm, Axel Walch, Margit Fuchs, et al.
New Biotechnology|December 10, 2023
Inter-patient heterogeneity in the hepatic ischemia-reperfusion injury transcriptome: Implications for research and diagnosticsSilvia Groiss, Christian Viertler, Marcel Kap, et al.
Histopathology|March 8, 2012
Antibody validation by combining immunohistochemistry and protein extraction from formalin-fixed paraffin-embedded tissuesClaudia Schuster, Katharina Malinowsky, Sibylle Liebmann, et al.
International Journal of Cancer|September 5, 2002
CDH1 c-160a promotor polymorphism is not associated with risk of stomach cancerPaul D P Pharoah, Carla Oliveira, José Carlos Machado, et al.
Radiation Research|April 25, 2003
Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted (d9) E-cadherin adhesion proteinMatthias Miederer, Christof Seidl, Gerd-Jürgen Beyer, et al.
Journal of Proteome Research|November 9, 2012
Variability of protein and phosphoprotein levels in clinical tissue specimens during the preanalytical phaseSibylle Gündisch, Stefanie Hauck, Hakan Sarioglu, et al.
Experimental Cell Research|May 25, 2002
Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitorsMargit Fuchs, Peter Hutzler, Ingrid Brunner, et al.
Pageof 11